Endothelin-1 and brain natriuretic peptide plasma levels decrease after aortic surgery.

BACKGROUND AND AIM OF THE STUDY Endothelin-1 (ET-1) and B-type natriuretic peptide (BNP) have been reported to be involved in numerous cardiovascular diseases. The study aim was to monitor the circulating plasma levels of these peptides in patients affected by aortic disease, and to identify any changes in such levels after surgical treatment. METHODS A total of 81 patients (52 males, 29 females; mean age 64 +/- 11 years) with aortic disease underwent surgery. The conditions included aortic valve stenosis (n=36), aortic valve regurgitation (n=11), ascending aortic aneurysm (n=6), and combined ascending aortic aneurysm and valvulopathy (n=28). Circulating plasma levels of ET-1 and BNP were measured in all patients before and at 12 months after surgery. RESULTS Compared to the preoperative situation, significant decreases were found postoperatively in plasma levels of ET-1 (4.2 +/- 0.1 versus 3.1 +/- 0.1 pM; p < 0.001) and BNP (0.071 versus 0.017 ng/ml; p < 0.001), combined with an increased cardiac function and decreased ventricular dimensions. The preoperative levels of both peptides were similar in all patient groups, and were decreased to a similar extent regardless of the diagnosis. Basal levels of ET-1 were higher in the trileaflet aortic valve compared to the bicuspid valve (4.0 +/- 0.1 versus 3.6 +/- 0.1 pM; p = 0.04). CONCLUSION Circulating plasma levels of ET-1 and BNP were decreased after surgery for aortic valve disease. The decrease was unrelated to the presence of ascending aortic aneurysm, and most likely represents a response to cardiac remodeling and the improved functional status of the patients.

[1]  A. Gottsäter,et al.  High Levels of Endothelin (ET)-1 and Aneurysm Diameter Independently Predict Growth of Stable Abdominal Aortic Aneurysms , 2010, Angiology.

[2]  J. Toole,et al.  Selective endothelin-1 receptor type A inhibition in subjects undergoing cardiac surgery with preexisting left ventricular dysfunction: Influence on early postoperative hemodynamics. , 2010, The Journal of thoracic and cardiovascular surgery.

[3]  Y. Soini,et al.  Increase in tissue endothelin-1 and ETA receptor levels in human aortic valve stenosis. , 2008, European heart journal.

[4]  A. Kerr,et al.  B-type natriuretic peptide and left ventricular dysfunction on exercise echocardiography in patients with chronic aortic regurgitation , 2007, Heart.

[5]  J. Pernow,et al.  The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. , 2007, Cardiovascular research.

[6]  H. Baumgartner,et al.  Big endothelin-1 is not a predictor in aortic stenosis, but is related to arterial blood pressure. , 2006, International journal of cardiology.

[7]  S. Ray,et al.  Natriuretic peptides in heart valve disease , 2005, Heart.

[8]  K. Chatterjee.  Neurohormonal activation in congestive heart failure and the role of vasopressin. , 2005, The American journal of cardiology.

[9]  J. Bartunek,et al.  Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[10]  C. Hamm,et al.  Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. , 2004, The American journal of cardiology.

[11]  R. Bonow,et al.  Elevated B-type natriuretic peptide in asymptomatic men with chronic aortic regurgitation and preserved left ventricular systolic function. , 2004, The American journal of cardiology.

[12]  J. Cohn,et al.  Ventricular remodeling in heart failure: a credible surrogate endpoint. , 2003, Journal of cardiac failure.

[13]  H. White,et al.  Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation. , 2003, The American journal of cardiology.

[14]  M. Drazner,et al.  B-type natriuretic peptide in cardiovascular disease , 2003, The Lancet.

[15]  J. Rouleau,et al.  Role of endothelins in congestive heart failure. , 2003, Canadian journal of physiology and pharmacology.

[16]  N. Fukuda,et al.  Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract. , 2003, The Journal of heart valve disease.

[17]  H. White,et al.  Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis , 2003, Circulation.

[18]  M. Holzer,et al.  Plasma endothelin in patients with acute aortic disease. , 2002, Resuscitation.

[19]  P. Mathisen,et al.  The effect of aortic valve replacement on N‐terminal natriuretic propeptides in patients with aortic stenosis , 2002, Clinical cardiology.

[20]  P. Mathisen,et al.  Natriuretic peptides in patients with aortic stenosis. , 2001, American heart journal.

[21]  D. Barnett,et al.  Plasma N‐terminal pro BNP and cardiotrophin‐1 are elevated in aortic stenosis , 2001, European journal of heart failure.

[22]  A. Linhart,et al.  [Humoral profile of patients with severe aortic stenosis]. , 2000, Casopis lekaru ceskych.

[23]  I. Yamaguchi,et al.  Effects of physiological or pathological pressure load in vivo on myocardial expression of ET-1 and receptors. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[24]  S. Vanni,et al.  Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. , 1999, Circulation research.

[25]  N. Prasada,et al.  Brain natriuretic peptide concentrations in patients with aortic stenosis , 1997 .

[26]  M. Komajda,et al.  Prognostic value of plasma endothelin-1 in patients with chronic heart failure. , 1997, European heart journal.

[27]  L. Jensen,et al.  Twenty-four-hour ambulatory blood pressure and vasoactive hormones in valvular aortic disease. , 1996, Blood pressure.

[28]  Y. Sugishita,et al.  Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. , 1993, Circulation research.

[29]  Y. Sugishita,et al.  Increased production of endothelin‐1 in the hypertrophied rat heart due to pressure overload , 1993, FEBS letters.

[30]  A. Carayon,et al.  [Neurohormonal profile in aortic valve stenosis]. , 1993, Archives des maladies du coeur et des vaisseaux.

[31]  Naoto Minamino,et al.  A new natriuretic peptide in porcine brain , 1988, Nature.

[32]  R. Paul,et al.  Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. , 1985, The American journal of physiology.